Like any medical procedure, mechanical thrombectomy for deep vein thrombosis carries recognized thrombectomy risks that patients should understand before consenting to treatment. No procedure is risk-free, and being informed about what can happen — and how often — helps set realistic expectations. This overview covers the main categories of risk without minimizing or overstating them.
Bleeding at the Access Site
Because thrombectomy requires vascular access, typically through a vein in the leg, some bleeding or bruising at the puncture site is common and usually minor. Less commonly, more significant bleeding can occur, particularly in patients on concurrent anticoagulation, which is one reason the access site is closely monitored in the hours immediately following the procedure.
Vessel Injury During the Procedure
Any catheter-based procedure carries a risk of injury to the vein wall, ranging from minor irritation to, rarely, perforation requiring additional intervention. Devices are designed with features intended to reduce this risk, such as tip designs that limit direct wall contact, but no design eliminates the possibility entirely. Interventionalists use imaging throughout the case to help minimize this risk and detect it early if it occurs.
What Is Distal Embolization and Why Does It Matter?
Distal embolization refers to a fragment of clot breaking loose and traveling further downstream, potentially causing a new obstruction in a smaller vessel or, in more serious cases, reaching the lungs as a pulmonary embolism. This is one of the primary risks that device design tries to address, since mechanical fragmentation inherently creates smaller clot pieces. Devices with built-in capture or containment features are intended to reduce, though not entirely eliminate, this risk.
Other Recognized Complications
Less common but recognized complications include allergic reaction to contrast media used during imaging, infection at the access site, and recurrent clot formation despite treatment. Some patients may also experience post-thrombotic syndrome over the longer term even after successful clot removal, particularly if the DVT had been present for an extended period before treatment. Rarely, a treated vein may develop restenosis or re-occlusion, which is monitored through follow-up imaging.
How Risk Is Managed and Monitored
Interventional teams take a range of precautions to reduce risk, including careful patient selection, use of real-time imaging throughout the procedure, and post-procedure monitoring before discharge. Devices designed with distal capture structures or aspiration capability alongside fragmentation are intended to reduce embolization risk as part of their engineering, though a qualified physician always weighs individual patient factors, such as clot location and bleeding risk, when selecting a specific technique or device.
Weighing Risk Against the Alternative
Any discussion of thrombectomy risk needs the context of what happens without treatment. Extensive, untreated proximal DVT carries its own risks, including prolonged limb swelling and a higher likelihood of post-thrombotic syndrome. Decisions about whether to proceed with thrombectomy are made by comparing these risks against the anticipated benefit for that specific patient — a conversation best had directly with the treating vascular specialist. Red-flag symptoms after any procedure, such as sudden severe leg pain, worsening swelling, chest pain, or shortness of breath, warrant seeking immediate medical care.
What symptoms after thrombectomy require urgent attention?
Sudden severe leg pain or swelling, chest pain, shortness of breath, or signs of significant bleeding at the access site should prompt seeking immediate medical care rather than waiting for a scheduled follow-up.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.